about
Suitability of selected chromatographic columns for analysis of fatty acids in dialyzed patients.Analysis of Outcomes of the NRS 2002 in Patients Hospitalized in Nephrology Wards.The peptidic middle molecules: is molecular weight doing the trick?Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.Hyper-Elongation in Colorectal Cancer Tissue - Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies.Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and MetabolismAlterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte MetabolismContribution of increased expression of stearoyl-CoA desaturase-1 in adipose tissue to serum content of monounsaturated fatty acids in patients with chronic kidney diseaseMultiplatform metabolomics provides insight into the molecular basis of chronic kidney diseasePotential contribution of monounsaturated fatty acids to cardiovascular risk in chronic kidney disease
P50
Q36368812-CAA1FD3D-236E-4845-981F-F088D53E6AB0Q37729849-EBF485A9-9BEF-4FE0-A676-B7D7A33C4951Q38208125-5C1BC1F4-48D1-4FC0-9CD6-E5D8F6DF5F39Q50183637-6F7280B0-2CB2-4796-BF37-B4E3BE691E20Q50884851-2B5A1D4D-76CC-428E-9B5F-4AC4466E1BD6Q57787928-A655916E-FB1E-4C95-B51F-11F6BC2D8390Q92164645-BD87824A-71D8-4160-8E7F-08E8B81D4EFCQ92871728-6BF93A3D-88B5-452D-BF35-5745A0AADF24Q93180368-E08270C1-BF11-4601-8C44-981D0602639BQ93235224-4A5AFD59-3CCE-40B7-9B07-B2B91B232A18
P50
description
researcher (ORCID 0000-0001-8126-8786)
@en
wetenschapper
@nl
name
Michal Chmielewski
@en
Michal Chmielewski
@nl
type
label
Michal Chmielewski
@en
Michal Chmielewski
@nl
prefLabel
Michal Chmielewski
@en
Michal Chmielewski
@nl
P31
P496
0000-0001-8126-8786